Research coauthored by RTI Health Solutions researchers will be presented at the National Kidney Foundation Spring Clinical Meetings.
Pooled data analysis of the long-term effect of Tolvaptan in patients between 56 and 65 years with Autosomal Dominant Polycystic Kidney Disease (ADPKD). Chebib FT, Zhou X, Garbinsky D, Davenport E, Sasikiran N, Oberdhan O, Fernandes A. Poster
